Evotec
Presence
Executives
View the org chart displaying its 42 main executives
Most searched biographies at Evotec
- Mario Polywka, Interim Chief Executive Officer and Director
- Elaine Sullivan, Member of the Supervisory Board
- Camilla Languille, Director
Popular executive movements at Evotec
- Christian Wojczewski will join the company as Chief Executive Officer on Jul. 1, 2024 (posted on April 25 2024).
- Aurélie Dalbiez will join the company as Chief People Officer on Jun. 15, 2024 (posted on April 17 2024).
- Mario Polywka who is Director, will be promoted to Interim Chief Executive Officer and Director on Mar. 2026 (posted on January 4 2024).
Click here to view some more movements at Evotec
Create your alert
to follow the executive moves at Evotec.
Pharmaceuticals
Evotec has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Evotec
- Breakpoint Therapeutics Announces Development Candidate Nomination and Start of IND-Enabling Activities of Potential Best-in-Class Polymerase Theta (Pol θ / POLQ) Inhibitor - Evotec
- Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline - Evotec
- Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic - Evotec
- Developing novel strategies against tuberculosis and malaria - Evotec
- Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV - Evotec
- Evotec SE: Invitation to Conference Call - Evotec
- Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb - Evotec
- Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies - Evotec
- Ad hoc: Evotec announces CEO transition - Evotec
- Evotec announces CEO transition - Evotec
- View more press releases Close
Social media about Evotec
- Evotec on Wikipedia, Google News & Yahoo Finance
- Evotec on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mario Polywka 
